William Petros

Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program of the Mary Babb Randolph Cancer Center, West Virginia University School of Medicine

Affiliated withWest Virginia University School of Medicine

Research Area

Medicine

Biography

William Petros has not added Biography.
If you are William Petros and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 15	2016

Other Publications

Article	Year
Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 11821447	2002
Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 11895898	2002
A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer. Cancer research\| PubMed ID: 12067983	2002
Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9... Cancer chemotherapy and pharmacology\| PubMed ID: 12111110	2002
Steady-state pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with end-stage renal disease receiving chronic dialysis. Antimicrobial agents and chemotherapy\| PubMed ID: 12121909	2002
Initial clinical trial of oral TAC-101, a novel retinoic acid receptor-alpha selective retinoid, in patients with advanced cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 12177113	2002
Introduction: pegfilgrastim, a new era in the management of chemotherapy-induced neutropenia. Pharmacotherapy\| PubMed ID: 12921215	2003
Marked variability of melphalan plasma drug levels during regional hyperthermic isolated limb perfusion. American journal of surgery\| PubMed ID: 14599607	2003
Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 14645433	2003
A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon. International journal of radiation oncology, biology, physics\| PubMed ID: 14967434	2004
Intraindividual variability in busulfan pharmacokinetics in patients undergoing a bone marrow transplant: assessment of a test dose and first dose strategy. Anti-cancer drugs\| PubMed ID: 15166618	2004
Pharmacogenomics in cancer therapy: is host genome variability important? Trends in pharmacological sciences\| PubMed ID: 15559247	2004
Associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 16087946	2005
Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in co... Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 16443517	2006
A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract. Cancer investigation\| PubMed ID: 16466986	2006
Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004). Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16533779	2006
Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16818699	2006
A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors. Cancer chemotherapy and pharmacology\| PubMed ID: 16819636	2007
Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxel. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16899612	2006
A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma. International journal of radiation oncology, biology, physics\| PubMed ID: 17881149	2008
Metabolism of the cysteine S-conjugate of busulfan involves a beta-lyase reaction. Drug metabolism and disposition: the biological fate of chemicals\| PubMed ID: 18474673	2008
Enterohepatic recirculation model of irinotecan (CPT-11) and metabolite pharmacokinetics in patients with glioma. Cancer chemotherapy and pharmacology\| PubMed ID: 18496691	2009
Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion. Annals of surgical oncology\| PubMed ID: 18528730	2008
Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia. Leukemia & lymphoma\| PubMed ID: 18766965	2008
Dehydroalanine analog of glutathione: an electrophilic busulfan metabolite that binds to human glutathione S-transferase A1-1. The Journal of pharmacology and experimental therapeutics\| PubMed ID: 18791061	2008
A phase I-II study of docetaxel and atrasentan in men with castration-resistant metastatic prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 18829508	2008
Building a statewide clinical trials network for cancer care in West Virginia. The West Virginia medical journal\| PubMed ID: 19999259	2009
Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumors. Anticancer research\| PubMed ID: 20044630	2009
HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinoma. PloS one\| PubMed ID: 20498858	2010
A phase I dose-escalation study of imatinib mesylate (Gleevec/STI571) plus capecitabine (Xeloda) in advanced solid tumors. Anticancer research\| PubMed ID: 20530436	2010
Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 20664361	2010
Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors. Cancer chemotherapy and pharmacology\| PubMed ID: 20972873	2011
A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE). Cancer chemotherapy and pharmacology\| PubMed ID: 21079958	2011
Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer. Oncology reports\| PubMed ID: 21971700	2012
A phase I multicenter study of continuous oral administration of lonafarnib (SCH 66336) and intravenous gemcitabine in patients with advanced cancer. Cancer investigation\| PubMed ID: 22011284	2011
Melphalan exposure induces an interleukin-6 deficit in bone marrow stromal cells and osteoblasts. Cytokine\| PubMed ID: 22356805	2012
Development and utilization of a combined LC-UV and LC-MS/MS method for the simultaneous analysis of tegafur and 5-fluorouracil in human plasma to support a phase I clinical study of oral UF... Journal of chromatography. B, Analytical technologies in the biomedical and life sciences\| PubMed ID: 22565063	2012
Effects of tobacco smoking and nicotine on cancer treatment. Pharmacotherapy\| PubMed ID: 23033231	2012
Duration of cisplatin excretion in breast milk. Journal of human lactation : official journal of International Lactation Consultant Association\| PubMed ID: 23492761	2013
Three-dimensional hierarchical plasmonic nano-architecture enhanced surface-enhanced Raman scattering immunosensor for cancer biomarker detection in blood plasma. ACS nano\| PubMed ID: 23659430	2013
Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 24166529	2013
Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancer. Cancer chemotherapy and pharmacology\| PubMed ID: 24619498	2014
A Prospective, Controlled Study of Acyclovir Pharmacokinetics in Obese Patients. Antimicrobial agents and chemotherapy\| PubMed ID: 26824940	2016